WideCells Group PLC presentation on stem cell technology in São Paulo, Brazil

WideCells Group PLC LON:WDC the healthcare services company focused on providing stem cell services and ground breaking insurance for stem cell treatment, has this morning told DirectorsTalk about its attendance at the Obstetrics and Gynaecology Conference in São Paulo, Brazil, 25-26 May 2017. At the conference, Dr Niranjan Bhattacharya, a preeminent figure in the stem cell industry and founding member of CellPlan’s Stem Cell Panel, will be making a presentation on stem cell technology and the developments both he and WideCells are driving within the industry.

Dr Bhattacharya’s expansive career in medical research focuses on cell and tissue therapy in degenerative disease and placental umbilical cord blood. He is currently the Head of the Department and Chair Professor of the Department of Regenerative Medicine and Translational Science, and is Director General of the Public Cord Blood Bank and Calcutta School of Tropical Medicine in Kolkata, India. Alongside this, he is a senior consultant in Obstetrics and Gynaecology and General Surgery in a number of premier private hospitals in Kolkata, India. Furthermore, as a founding member of the Stem Cell Panel, he is responsible for reviewing patient cases for CellPlan, the Company’s innovative stem cell insurance product, providing and managing a panel of expert doctors who provide secondary medical opinion to WideCells/CellPlan patients, and ultimately helping to ensure that the Company’s competitive service offering and insurance policy remains fully reflective of industry developments.

For further information on the conference please visit http://www.sogesp.com.br/eventos/xi-jornada-de-obstetricia-e-ginecologia-de-campinas-e-regiao-e-xi-encontro-dos-ex-residentes

 

Click to view all articles for the EPIC:
Or click to view the full company profile:
    Facebook
    Twitter
    LinkedIn
    WideCells Group PLC

    More articles like this

    WideCells Group PLC

    Umbilical blood injects new life into 8-month-old baby

    An 8-month-old girl who had severe combined immune deficiency (SCID) underwent a successful hematopoietic stem cell transplant surgery in Shanghai. The stem cell was taken from umbilical cord blood. Widecells Group PLC (LON:WDC) are leading a

    WideCells Group PLC

    Leukaemia: A Guide To The Cancer Of The Blood

    It is not hereditary, and it is not contagious. It is, however, one of the diseases that kills more children than many others. The word ‘leukaemia’ refers to a group of cancers that spread through the

    WideCells Group PLC

    Autism Treated With Stem Cells

    Researchers at Duke University have utilized autologous (the patient’s own) stem cell infusions to promote increased connectivity in the brain that allowed for improved communication and language abilities in children with Autism Spectrum Disorder (ASD). The

    WideCells Group PLC

    Cord blood banking industry expected to grow

    The list of decisions for new parents already seems endless but it continues to grow as new advances in medicine and technology open new doors for healthcare. Many private companies offer services for collecting and storing